Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus | NEJM
Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery | NEJM
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM
Frontiers | Engineered Cell-Based Therapeutics: Synthetic Biology Meets Immunology
Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia
Frontiers | Gangliosides: Treatment Avenues in Neurodegenerative Disease
Once-Weekly Semaglutide in Adolescents with Obesity | NEJM
PDF) Reduced Treatment Intensity In Patients With Early-Stage Hodgkin's Lymphoma
J. Michael Ryan, MD (@JMichael_Ryan) / Twitter
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus
Value-Added Use of Clinical Study Data: - ppt download
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM
Biweekly Update 13-August 2021
Once-Weekly Semaglutide in Adolescents with Obesity | NEJM
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM
The HIV Prevention Trials Network | Prevention Now
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus | NEJM
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM
Can exercise bring down high cholesterol? - Quora
Outcomes of Daytime Procedures Performed by Attending Surgeons after Night Work | NEJM
Oscar Lahoud (@DrOscarLahoud) / Twitter
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus | NEJM
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy | NEJM
Evidence-based Practice in Infection Control and Prevention
Once-Weekly Semaglutide in Adolescents with Obesity | NEJM
Once-Weekly Semaglutide in Adolescents with Obesity | NEJM
